Cost-effectiveness and cost-utility analysis of somatrogon once-weekly injections vs. daily growth hormone injection for treating paediatric growth hormone deficiency in Ireland.

Simone Rivolo Jane Loftus Balazs PeterMarion FaheyThitima Kongnakorn

Published in: Journal of medical economics (2023)

Somatrogon weekly injections were estimated to result in higher NAH, higher QALYs, lower overall costs and lower costs per cm gained than dGHs, in pGHD.

Keyphrases

growth hormone
ultrasound guided
platelet rich plasma
intensive care unit
emergency department
physical activity
smoking cessation